Home » Posts tagged 'pharmaceutical intellectual property'

pharmaceutical intellectual property

CETA: An Opportunity to Fix Canada's Broken Pharmaceutical Patent Linkage System

CETA: An Opportunity to Fix Canada's Broken Pharmaceutical Patent Linkage System

This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on a subject related to industrial or intellectual property law.  The full paper will appear in the upcoming edition of the Intellectual Property Journal (IPJ). In September of 2014 the consolidated […]

Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws

Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws

A little over a week ago, the Fraser Institute, a prominent and independent Canadian public policy think tank, released a report calling for a strengthening of intellectual property protection for pharmaceuticals in Canada. The report claims that the changes would produce an increase in trade opportunities and access to foreign markets that would generate an […]